Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 22Myelodysplastic Syndromes 2Targeted Therapy 1Recurrence 1Neoplasm, Residual 1Myelodysplastic-Myeloproliferative Diseases 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Biphenotypic, Acute 1Infections 1Hematologic Neoplasms 1Disease 1Carcinoma, Non-Small-Cell Lung 1Blast Crisis 1

Interventions

Blood Specimen Collection 9Surveys and Questionnaires 5Magnetic Resonance Spectroscopy 5Biopsy 5Prednisone 4Colonoscopy 4Biopsy, Fine-Needle 4Tomography, X-Ray Computed 3Surgical Procedures, Operative 3Mammography 3Magnetic Resonance Imaging 3Liquid Biopsy 3Lenalidomide 3Interviews as Topic 3Exercise 3Diagnostic Tests, Routine 3Cyclophosphamide 3weifuchun 2pembrolizumab 2obinutuzumab 2Urination 2Preoperative Exercise 2Positron Emission Tomography Computed Tomography 2Observation 2Methods 2Melphalan 2Immunohistochemistry 2Hematologic Tests 2Gemcitabine 2Educational Status 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Disease × gilteritinib × Clear all
NCT06667973 2025-03-12

Efficacy of Gilteritinib in Combination With FLAI as Induction Therapy of FLT3-positive Acute Myeloid Leukemia

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase 2 Not yet recruiting
80 enrolled
Other hematologic neoplasm

Disease, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡